CDC42 and breast cancer: Kaplan–Meier OS analysis of breast cancer patients revealed that low expression of FBXW7, SRGAP2, MTMR3 as well as CDC42, the partner of CDC42BPA, is associated with poor prognosis (Supplementary Fig. S5a).